BREAKING: FDA advisers recommend that the agency approve the country’s first RSV vaccine for older people, a shot from Pfizer for adults ages 60 and up.
The FDA's independent Vaccines and Related Biological Products Advisory Committee voted 7-4 in favor of recommending the vaccine based on its efficacy, with one abstention. The single-dose shot was shown to reduce the risk of illness from respiratory syncytial virus by as much as 86%,The next step is for the FDA to approve the vaccine, which could take several months, though the agency usually follows the advisory committee’s recommendations.
The second may be close on its heels. The advisory committee will meet again Wednesday to evaluate the safety and efficacy of a similar RSV vaccine for older adults, this one from GlaxoSmithKline. Trial dataearlier this month in the New England Journal of Medicine showed that the shot lowered the risk of symptomatic illness by 83% and of severe illness by 94% in adults ages 60 and up.
RSV causes lower respiratory illness, though for most healthy adults the symptoms are mild. In serious cases, however, RSV can lead to bronchiolitis, which causes airways to become inflamed and clogged with mucus, or pneumonia.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns of Guillain-Barre syndrome as possible risk of Pfizer’s RSV vaccineGuillain-Barre syndrome, or inflammatory neuropathy, is a disorder in which the body’s immune system mistakenly attacks the nerves.
Read more »
Pfizer, GSK face FDA panel review in race for RSV vaccinesThe frontrunners in a crowded race to develop the first respiratory syncytial virus (RSV) vaccine - Pfizer Inc and GSK - will face scrutiny from a panel of experts to the U.S. Food and Drug Administration this week.
Read more »
FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks
Read more »
Doctors who touted ivermectin as covid fix now pushing it for flu, RSVFirst, the group of doctors championed ivermectin as a covid panacea. It failed to live up to the hype. Now, they’re promoting the anti-parasitic to prevent and treat the flu and RSV.
Read more »
A single injection could protect babies against RSV over winterRSV infections kill around 100,000 children each year, but now an antibody injection has proven safe and effective at reducing the risk from the disease.
Read more »
FDA authorizes first at-home joint flu, COVID-19 testThe Food and Drug Administration has issued an emergency use authorization for the first over-the-counter at-home test than can detect whether someone has the flu or COVID-19.
Read more »